Safety first when conducting an endoscopy

Endoscopy is a very important diagnostic and therapeutic tool in medical practice, offering invaluable insights into gastro-intestinal health. Despite its significant benefits, endoscopy is an invasive procedure with associated risks and complications that necessitate careful consideration, particularly in vulnerable patients.

There are some recognized complications related to endoscopy procedures all over the world that include bleeding, perforation, and sedation-related cardio-respiratory risk. These risks are notably higher in frail and elderly patients, those with obstructive sleep apnoea (OSA), high body mass index (BMI) (≥35 kg/ m2), or comorbid conditions such as heart and lung conditions, decompensated liver cirrhosis, chronic renal failure and pregnancy. 

Therefore, endoscopists must exercise heightened caution when dealing with high-risk patients, and justify the benefits of an endoscopy against potential risks before proceeding.

In the UK, over 2.5 million gastrointestinal endoscopic procedures are performed annually. On the day of the procedure, a trained nurse receives the patient and records all relevant medical history and current medications. This is then followed by the endoscopist explaining the procedure and potential complications and only when the patient is satisfied with the information, the patient provides written signed consent. If the patient lacks mental capacity, the consent form must be signed by the referring physician/next of kin.

Time slot

An appropriate time slot should be allocated based on procedure indications and patient characteristics. A standard diagnostic endoscopy (OGD) should have a minimum slot of 20 minutes, with the procedure itself taking at least 7 minutes. Similarly, a standard diagnostic colonoscopy should be allocated a minimum slot of 40 minutes, with a minimum caecal withdrawal time of 6 minutes. These recommended time slots are important to ensure the endoscopist has sufficient time to complete a standard examination.

Pre-assessment

To reduce the risk of sedation-related complications, pre-assessment to balance the indication and intended aim of the procedure against the physical status of the patient. For patients with OSA and/or high BMI, enhanced periprocedural monitoring is essential as they may be at an increased risk of periprocedural apnoea

Sedation

Endoscopies are carried out with a local anaesthetic throat spray, with or without sedation (midazolam). Sedation is commonly used for gastrointestinal endoscopy, but the type and amount of sedation administered is influenced by the complexity and nature of the procedure and patient factors. 

In the UK, the vast majority of sedated procedures use benzodiazepines, with or without opiates, whereas deeper sedation with propofol or general anaesthetic requires an anaesthetic team. The patient’s comfort and sedation should be measured, recorded and continually assessed during the procedure and sedation/analgesia titrated appropriately.

Patients undergoing gastrointestinal endoscopy need to have a clear understanding of their sedation options, including the choice of no sedation and alternatives, to balance the intended aims of the procedure and reduce the risk of complications. Shared decision-making with patients regarding sedation options ensures their comfort and safety.

Procedure room

In the procedure room, monitoring of pulse, blood pressure, oxygen saturation, and respiration rates is a minimum requirement for all patients, with supplemental oxygen provided for any level of sedation. 

Where the endoscopist-sedationist administers sedation and performs the procedure, there must be at least an appropriately trained second member of the team monitoring the patient’s status and recording all of the administered drugs during the procedure. 

For patients undergoing endoscopy under deep sedation (propofol) or general anaesthetic, ECG, automated non-invasive blood pressure, capnography and core body temperature should be monitored and recorded.

Recovery and discharge

Recovery and discharge protocols include extending the monitoring of sedation into the recovery period until the patient’s conscious state returns to baseline. This requires sufficient staff trained in sedation, monitoring, and the recognition of complications. 

The endoscopist-sedationist should be responsible for ensuring the safety and complete recovery of the patient following the procedure. A formal assessment of the patient's suitability for discharge is conducted to ensure recovery from sedation and the absence of complications. 

Patients receiving sedation and/or analgesia are advised against driving, riding a bicycle, operating machinery, signing legal documents, making important decisions, or consuming alcohol for 24 hours post-procedure.

Reversal agents

In patients with opiate or benzodiazepine-induced respiratory depression during or following endoscopy, the use of a relevant reversal agent is recommended. All endoscopy rooms (or units) stock flumazenil and naloxone; and all endoscopy clinical staff should be aware of where they are stored and how to access them in case of sedation-related emergencies.

High-risk groups

Special considerations are given to high-risk groups, including the frail, elderly, or comorbid patients. Clinicians conduct thorough discussions with these patients regarding the benefits and risks of sedation and alternative options including no sedation. 

By adhering to these guidelines, endoscopists can significantly reduce the risks associated with gastrointestinal endoscopy, ensuring patient safety and successful outcomes. 

Dr Mohammad Mosharof Hossain, Associate Teacher, University of Kent and Consultant Gastroenterologist and Clinical Lead Morbidity and Mortality Medway NHS Foundation Trust, Gillingham, England, UK.